Harvard Bioscience ROE 2012-2026 | HBIO
Current and historical return on equity (ROE) values for Harvard Bioscience (HBIO) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Harvard Bioscience ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2026-03-31 | $-0.01B | $0.01B | -66.67% |
| 2025-12-31 | $-0.06B | $0.02B | -379.66% |
| 2025-09-30 | $-0.05B | $0.03B | -196.30% |
| 2025-06-30 | $-0.06B | $0.04B | -143.40% |
| 2025-03-31 | $-0.06B | $0.05B | -110.48% |
| 2024-12-31 | $-0.01B | $0.07B | -19.70% |
| 2024-09-30 | $-0.02B | $0.07B | -21.90% |
| 2024-06-30 | $-0.01B | $0.07B | -15.55% |
| 2024-03-31 | $-0.01B | $0.07B | -12.37% |
| 2023-12-31 | $0.00B | $0.07B | -4.05% |
| 2023-09-30 | $0.00B | $0.07B | -4.07% |
| 2023-06-30 | $-0.01B | $0.07B | -6.83% |
| 2023-03-31 | $0.00B | $0.07B | -2.70% |
| 2022-12-31 | $-0.01B | $0.08B | -13.42% |
| 2022-09-30 | $-0.01B | $0.08B | -9.06% |
| 2022-06-30 | $0.00B | $0.08B | -5.10% |
| 2022-03-31 | $-0.01B | $0.08B | -7.62% |
| 2021-12-31 | $0.00B | $0.08B | 0.00% |
| 2021-09-30 | $0.00B | $0.08B | -2.58% |
| 2021-06-30 | $0.00B | $0.08B | -3.87% |
| 2021-03-31 | $-0.01B | $0.08B | -6.51% |
| 2020-12-31 | $-0.01B | $0.08B | -11.76% |
| 2020-09-30 | $-0.01B | $0.08B | -9.00% |
| 2020-06-30 | $-0.01B | $0.08B | -11.58% |
| 2020-03-31 | $-0.01B | $0.08B | -8.89% |
| 2019-12-31 | $0.00B | $0.08B | -5.02% |
| 2019-09-30 | $0.00B | $0.08B | -2.50% |
| 2019-06-30 | $0.00B | $0.08B | 1.23% |
| 2019-03-31 | $0.00B | $0.08B | 0.00% |
| 2018-12-31 | $0.00B | $0.08B | -2.50% |
| 2018-09-30 | $0.00B | $0.08B | -5.03% |
| 2018-06-30 | $0.00B | $0.08B | -5.10% |
| 2018-03-31 | $0.00B | $0.08B | -3.85% |
| 2017-12-31 | $0.00B | $0.08B | 0.00% |
| 2017-09-30 | $0.00B | $0.07B | -2.69% |
| 2017-06-30 | $0.00B | $0.07B | -5.41% |
| 2017-03-31 | $-0.01B | $0.08B | -6.71% |
| 2016-12-31 | $-0.01B | $0.08B | -6.60% |
| 2016-09-30 | $-0.02B | $0.08B | -27.18% |
| 2016-06-30 | $-0.02B | $0.08B | -24.46% |
| 2016-03-31 | $-0.02B | $0.09B | -22.03% |
| 2015-12-31 | $-0.02B | $0.09B | -21.23% |
| 2015-09-30 | $0.00B | $0.09B | -2.13% |
| 2015-06-30 | $0.00B | $0.10B | 0.00% |
| 2015-03-31 | $0.00B | $0.10B | 1.05% |
| 2014-12-31 | $0.00B | $0.10B | 3.11% |
| 2014-09-30 | $0.00B | $0.10B | 2.08% |
| 2014-06-30 | $0.00B | $0.10B | 0.00% |
| 2014-03-31 | $0.00B | $0.10B | -0.99% |
| 2013-12-31 | $0.00B | $0.10B | -1.95% |
| 2013-09-30 | $0.00B | $0.11B | 0.00% |
| 2013-06-30 | $0.00B | $0.10B | 0.97% |
| 2013-03-31 | $0.00B | $0.10B | 1.97% |
| 2012-12-31 | $0.00B | $0.10B | 3.00% |
| 2012-09-30 | $0.00B | $0.10B | 3.07% |
| 2012-06-30 | $0.00B | $0.10B | 3.10% |
| 2012-03-31 | $0.00B | $0.10B | 3.11% |
| 2011-12-31 | $0.00B | $0.10B | 4.19% |
| 2011-09-30 | $0.01B | $0.09B | 5.31% |
| 2011-06-30 | $0.02B | $0.09B | 19.51% |
| 2011-03-31 | $0.02B | $0.09B | 21.90% |
| 2010-12-31 | $0.02B | $0.08B | 23.10% |
| 2010-09-30 | $0.02B | $0.08B | 26.75% |
| 2010-06-30 | $0.01B | $0.08B | 12.08% |
| 2010-03-31 | $0.01B | $0.07B | 9.56% |
| 2009-12-31 | $0.01B | $0.07B | 9.86% |
| 2009-09-30 | $0.01B | $0.07B | 7.25% |
| 2009-06-30 | $0.01B | $0.07B | 7.25% |
| 2009-03-31 | $0.00B | $0.07B | 4.26% |
| 2008-12-31 | $0.00B | $0.07B | 2.74% |
| 2008-09-30 | $0.00B | $0.08B | -1.34% |
| 2008-06-30 | $0.00B | $0.08B | -1.32% |
| 2008-03-31 | $0.00B | $0.08B | -1.34% |
| 2007-12-31 | $0.00B | $0.07B | -2.71% |
| 2007-09-30 | $0.00B | $0.07B | -4.10% |
| 2007-06-30 | $0.00B | $0.07B | -5.52% |
| 2007-03-31 | $0.00B | $0.07B | -2.77% |
| 2006-12-31 | $0.00B | $0.07B | -1.40% |
| 2006-09-30 | $-0.01B | $0.07B | -11.35% |
| 2006-06-30 | $-0.01B | $0.07B | -9.82% |
| 2006-03-31 | $-0.03B | $0.07B | -43.21% |
| 2005-12-31 | $-0.03B | $0.08B | -39.88% |
| 2005-09-30 | $-0.02B | $0.09B | -24.65% |
| 2005-06-30 | $-0.02B | $0.10B | -22.98% |
| 2005-03-31 | $0.00B | $0.10B | 1.96% |
| 2004-12-31 | $0.00B | $0.10B | 1.98% |
| 2004-09-30 | $0.00B | $0.10B | 3.00% |
| 2004-06-30 | $0.00B | $0.10B | 3.05% |
| 2004-03-31 | $0.00B | $0.10B | 4.16% |
| 2003-12-31 | $0.01B | $0.09B | 5.35% |
| 2003-09-30 | $0.00B | $0.09B | 2.20% |
| 2003-06-30 | $0.00B | $0.09B | 1.17% |
| 2003-03-31 | $0.00B | $0.08B | 1.25% |
| 2002-12-31 | $0.00B | $0.08B | 1.34% |
| 2002-09-30 | $0.00B | $0.07B | 2.88% |
| 2002-06-30 | $0.00B | $0.07B | 2.93% |
| 2002-03-31 | $0.00B | $0.07B | -5.99% |
| 2001-12-31 | $-0.01B | $0.07B | -7.72% |
| 2001-09-30 | $0.03B | $0.06B | 47.54% |
| 2001-06-30 | $0.01B | $0.05B | 25.95% |
| 2001-03-31 | $-0.05B | $0.03B | -150.00% |
| 2000-12-31 | $-0.05B | $0.02B | -326.67% |
| 2000-09-30 | $-0.08B | $0.00B | -2050.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Scientific Instruments Manufacturing | $0.019B | $0.087B |
| HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bruker (BRKR) | United States | $5.722B | 20.54 |
| Kewaunee Scientific (KEQU) | United States | $0.100B | 8.24 |